EHRA Premium Access

The triangle correlation among the impact on serum S100B protein release, incidence of the silent cerebral ischemic phenomena and pulsed field ablation for patients with atrial fibrillation.

Topic: Rhythm Control, Catheter Ablation


About the speaker

Professor Kyoung-Ryul Julian Chun

CardioVascular Center Bethanien (CCB), Frankfurt am Main (Germany)
13 presentations
1 follower

6 more presentations in this session

Persistent phrenic nerve palsy after atrial fibrillation ablation: follow-up data from the Netherlands Heart Registration

Speaker: Doctor J. de Jong (Amsterdam, NL)


Pulsed field ablation as the first choice regarding oesophageal safety for atrial fibrillation ablation?

Speaker: Doctor J. Katic (Split, HR)


Impact of high-power and very high-power short-duration radiofrequency ablation on procedure characteristics and first-pass isolation during pulmonary vein isolation

Speaker: Doctor Z. Sallo (Budapest, HU)


Areas of minimal generator impedance drop during the index atrial fibrillation ablation correlate with pulmonary vein reconnection sites despite adopting the CLOSE protocol

Speaker: Doctor A. Malaweera (London, GB)


Comparison of left atrial lesion size and troponin release of two novel single shot devices for pulmonary vein isolation: pulsed field ablation vs. multi-electrode radiofrequency balloon

Speaker: Doctor M. Lemoine (Hamburg, DE)


Access the full session

Moderated ePosters - News on AF ablation

Speakers: Professor K. Chun, Doctor J. de Jong, Doctor J. Katic, Doctor Z. Sallo, Doctor A. Malaweera...

About the event


EHRA 2022

3 April - 5 April 2022

Sessions Presentations

Related content

EHRA Premium Access

Detection of endo-epicardial atrial low-voltage areas using unipolar and omnipolar voltage mapping

3 April 2022

EHRA Premium Access

Atrial high-rate episodes in patients with devices without a history of atrial fibrillation

3 April 2022

EHRA Premium Access

Pulsed field ablation of atrial fibrillation: recurrence rate after first pulmonary vein isolation and first insights into durability at redo procedures

3 April 2022

This platform is supported by

logo Novo Nordisk